Effects of geldanamycin and thalidomide on the Th1/Th2 cytokine balance in mice subjected to operative trauma.

Takumi Nakano,K. Araki,Hajime Nakatani,Michiya Kobayashi,Takeki Sugimoto,Y. Furuya,Takanori Matsuoka,Toufeng Jin,K. Hanazaki

DOI: https://doi.org/10.1016/J.SURG.2006.10.003

IF: 4.348

2007-04-01

Surgery

Abstract:

What problem does this paper attempt to address?

[Risk factors for arrhythmia early after transcatheter closure of perimembranous ventricular septal defects]

Xian-jun Sun,Wei Gao,Ai-qing Zhou,Zhi-qing Yu,Fen Li,Mei-rong Huang,Kun Sun

Abstract:Objective: Perimembranous ventricular septal defects (PMVSDs) is the most common type of congenital ventricular septal defects (VSD), which accounts for 70% approximately 80% of VSD. The structure of PMVSDs is very complex, it is close to tricuspid valve, mitral valve and aortic valve. The atrioventricular (AV) node is located in the posterior upper membranous ventricular septum and branches into left and right bundle in the posterior lower margin. This increases the risk of transcatheter closure of PMVSDs. Arrhythmias is the common complication after transcatheter closure of PMVSDs. The present study aimed to identify the risk factors resulting in arrhythmias after transcatheter closure of PMVSDs in patients under 18 years of age to decrease the incidence of arrhythmias after the interventional catheterization. Methods: A retrospective analysis was performed on the patients treated with transcatheter intervention from June 2002 to June 2004. Transcatheter closure of PMVSDs with Amplatzer membranous septal occluder and a domestic product was performed in 89 cases after obtaining consent themselves and/or their guardian or parents, 47 cases were males and 42 females. The age of the cases ranged from 3 to 18 years (mean 8.2 years) and the body weight ranged from 13 to 55 kg (mean 26.7 kg). They were all diagnosed as having PMVSDs with trans-thoracic echocardiography (TTE) before the interventional catheterization, the electrocardiographic (ECG) and chest X-ray (CXR) findings were recorded. A simultaneous care ECG and TTE were performed during operation in order to identify the effect of the transcatheter closure, the heart structure and functional changes and whether or not arrhythmias occurred, respectively. In 80 cases AGA Amplatzer membranous septal occluder was used and in 9 cases a domestic product was used. Follow-up was performed based on the echocardiography and ECG. Results: The devices were successfully implanted in 89 cases; 11 cases (12%) developed various block of heart conduction within 5 days, which included first degree AV block in 1 patient, third degree AV block in 1, left anterior bundle branch block in 5, partial right bundle branch block in 4, complete right bundle branch block in 3, and 3 patients had two kinds of heart block. Eight patients were treated with corticosteroids, 6 of them recovered within 14 days, 1 patient within 1 month and in 1 case the problem shifted from first degree block and left anterior bundle branch block to left anterior bundle branch block 5 days later and that persisted for 6 months. It was found that the distance from upper margin of defects to the aortic valve < 3 mm, the diameter of ventricular septal defect > or = 8 mm, the diameter of device > or = 10 mm, blood pH < 7.35 and arteriovenous track building time after the success of the Seldinger technique > or = 60 min were independent predictors of post-closure arrhythmias. Conclusion: Arrhythmias remain the severe early complications after interventional catheterization for PMVSDs in patients under 18 years of age. Shortening of operation time, prevention of acidosis and strict selection of indications may be the most effective measures to prevent arrhythmias after transcatheter closure of PMVSDs in patients under 18 years of age.
[Risk factors for early arrhythmias post transcatheter closure of perimembranous ventricular septal defects]

Xian-yang Zhu,Yu-hao Liu,Chuan-ju Hou,Xiu-min Han,Xiao-tang Sheng,Duan-zhen Zhang,Chun-sheng Cui,Qi-guang Wang,Dong-an Deng,Yu-wei Zhang

Abstract:Objective: To analyze the risk factors for early arrhythmias after transcatheter closure of perimembranous ventricular septal defect (PVSD). Methods: A total of 358 patients [161 males, aged from 3 to 54, mean (10.9 +/- 8.1) years, body weight from 12 to 90, mean (32.8 +/- 17.2) kg] who underwent transcatheter closure of PVSD from August 2002 to February 2006 were included in this retrospective analysis. Electrocardiogram was performed daily after transcatheter closure for seven days. Relationships between arrhythmias and those risk factors such as the defect characteristics and the device size and types were explored by logistic regression analysis. Left ventriculography showed 195 out of 358 patients with PVSD were complicated with membranous aneurysm. The PVSD diameter ranged from 2 to 18 (6.5 +/- 3.1) mm in left ventricular side and from 2 to 12 (4.2 +/- 2.3) mm in right ventricular side. A total of 140 nonsymmetrical and 218 symmetrical occluders with diameter 4 to 18 (8.1 +/- 2.5) mm were used to close those defects. Results: Procedure was successful in all patients. Early arrhythmias after transcatheter closure of PVSD were observed in 135 (37.7%) patients and serious cardiac arrhythmias in 23 (6.4%) patients. The early arrhythmias after transcatheter closure of PVSD were significantly correlated with device size [> or = (8.6 +/- 2.7) mm] and type (nonsymmetrical device), the span between the defect and tricuspid (< or = 3 mm), and the presence of aneurysm. Conclusion: Larger device size, nonsymmetrical device, narrow span between the defect and tricuspid and the presence of aneurysm are the risk factors for early arrhythmias after transcatheter closure of PVSD.
Non-fluoroscopic percutaneous transcatheter closure of atrial septal defects in children under transesophageal echocardiographic guidance

Wei-Ze Xu,Xin-Yi Shou,Jian-Hua Li,Jian-Gen Yu,Ze-Wei Zhang,Jin Yu,Jing-Jing Ye

DOI: https://doi.org/10.1007/s12519-018-0179-x

2018-01-01

Abstract:Background This study sought to investigate the feasibility, safety and effectiveness of transcatheter closure of atrial septal defects (ASDs) under the guidance of transesophageal echocardiography (TEE) in children. Methods We reviewed the medical records of patients who underwent percutaneous ASD closure at our center from August 2016 to December 2017. For a total of 88 patients who were identified as having a single-hole defect and were undergoing percutaneous transcatheter ASD closure, a procedure completely guided by TEE was performed. There were 31 male patients and 57 female patients. The patients’ mean age was 60.09 ± 36.42 months (13–182 months), and their mean body weight was 20.16 ± 10.04 kg (9–77 kg). Patients were followed up by performing transthoracic echocardiography and obtaining chest X-rays and electrocardiograms. Results The transcatheter closure of ASDs was successful in all patients. The mean ASD size was 11.58 ± 5.31 mm (3–28 mm), and the mean size of the occlusion device was 16.07 ± 5.29 mm (6–36 mm). The mean procedural times were 13.33 ± 2.82 minutes (6–16 minutes). The mean hospitalization costs were 27,259.66 ± 2507.04 RMB (25,200.00–33,911.45 RMB). The mean postoperative hospital stay was 3.22 ± 0.53 days (3–5 days). Residual shunt, occlusion device shedding or displacement, and pericardial effusion were not observed during or after the operation. Conclusion Percutaneous transcatheter ASD closure completely guided by TEE is a feasible, safe, non-invasive and easy procedure.
Minimally Invasive Experiences on Perventricular Device Closure of Ventricular Septal Defects in Children

CHEN Jun-xian,YU Cheng-zhong,ZHANG Ze-wei

DOI: https://doi.org/10.3760/cma.j.issn.0253-3006.2012.12.002

2012-01-01

Abstract:Objective To introduce the minimally invasive experiences on perventricular device closure of ventricular septal defects (VSDs) under transesophageal echocardiography (TEE) guidance in two children hospital heart centers.Methods 142 cases of VSDs undertook perventricular device closure under TEE guidance in two centers between July 2007 and July 2011,in which perimembranous VSDs was found in 95 cases,intracristal VSDs in 37 cases and muscular VSDs in 10 cases.Their clinical data was retrospectively analyzed.The diameter of the VSD ranged from 3.0 to 8.5 mm (mean4.7 mm) by TTE,and ranged from 2.5 to 8.0 mm (mean 4.3 mm) by TEE.Results The procedures was completed successfully in 140 cases (97.2％).1 patient (0.7％) was complicated with Ⅲ atrialventricular conduction block in post-operation 5th day.VSD was closed with CPB in the secondary operation,the patient gradually reached to sinus rhythm in post-operation.The device in 1 patient (0.7％) fell off and located in the left pulmonary artery after the operatior.The device was taken out and followed by VSD closure with CPB in the secondary operation.Concentric devices were used in 93cases and eccentric devices were used in 47 cases.During fellow-up,no clinically significant complications were found.Conclusions The minimally invasive penventricular device closuer of VSD without CPB is a safe and effective therapy in children.It should be encouraged in clinical practice.
Application of Transesophageal Echocardiography in High Ventricular Septal Defect Closure Via the Small Intercostal Incision with Eccentric Occluder in Children

Yu Jin,Ye Jingjing,Zhang Zewei,Li Jianhua,Qian Jingjing,Yang Xiuzhen,Ma Lianglong

DOI: https://doi.org/10.3760/cma.j.issn.1004‐4477.2019.10.004

2019-01-01

Abstract:Objective To explore the value of transesophageal echocardiography ( T EE ) in high ventricular septal defect ( VSD) occlusion via a left parasternal ultra‐minimal intercostal incision ( ≤1 cm ) with eccentric occluder in children . Methods Forty‐eight children with high VSD underwent device occlusion via ultraminimal intercostal incision with eccentric occluder . T he w hole operation , including preoperative evaluation ,intraoperative localization and guidance and postoperation evaluation were performed under the guidance of T EE . Results Forty‐six children with high VSD underwent successfully device closure in all 48 cases and the operation success rate was 95 .8% . T he average size of high VSD was 2 .2－6 .0 ( 3 .70 ± 0 .90) mm and the average size of eccentric occluder was 4－8 ( 5 .48 ± 1 .12) mm . T he average operation duration was 18－98 ( 49 .80 ± 16 .71) min . T here were 2 cases of peri‐membranous high VSD and 44 cases of outlet‐typle VSD ,of w hich 10 cases of mild aortic valve prolapses ( AVOP) ,including 5 cases of aortic valve regurgitation ( AR ) . In addition ,there was 1 case of replacement of device ,1 case of having septum below the margin of the defect and 1 case of using a dilator for a small defect . T he 46 cases were followed up for 6 to 42 months ,and the pericardial effusion occured in 3 cases and disappeared during follow‐up . No other abnormal conditions were found . Conclusions During the surgery of high VSD device occlusion via ultraminimal intercostal incision with eccentric occluder ,T EE has an important value in defect assessment ,intraoperative localization and guidance ,and immediate evaluation of efficacy ,and can effectively guide the device occlusion of high VSD .
Minimally Invasive Perventricular Device Closure of Perimembranous Ventricular Septal Defect Without Cardiopulmonary Bypass: Multicenter Experience and Mid-Term Follow-Up

Quansheng Xing,Silin Pan,Qi An,Zewei Zhang,Jianhua Li,Feng Li,Qin Wu,Zhongyun Zhuang

DOI: https://doi.org/10.1016/j.jtcvs.2010.01.018

2011-01-01

Abstract:：ObjectiveTransesophageal echocardiography (TEE) guided, minimally invasive perventricular deviceocclusion of ventricular septal defects ( VSDs) without cardiopulmonary bypass ( CPB) hasbeen applied in multiple centers. We reported experiences and the mid-term results.Methods Four hundred and thirty-two cases from 4 cardiac centers were involved in thestudy. There were 235 males and 197 females, aged from 3 months to 15 years, with a bodyweight varying from 4.0 to 26.0 kg. Three hundred and fifty-one patients hadperimembranous VSDs, 57 had intracristal or supracristal VSDs and 24 had muscular VSDs (17had multiple muscular VSDs). The diameter of the VSD ranged from 3 to 12 (5.3 ±1.6 )mm.For those with perimembranous or muscular VSDs, a 3 to 5 cm inferior sternotomy wasmade, but for those with intracristal or supracristal VSDs, a 2 to 3 cm incision was madeparastemally through the left third intercostal space. Being monitored and guided withTEE, the device was deployed to occlude the VSD through the puncture at the free wall ofthe right ventricle. TEE was used for assessing the residual shunting, the left and rightventricular outlet tracts, valvular function and for detecting any arrhythmia, The deviceswould be released if the heart rhythm was normal, as well as the residual shunting andvalvular regurgilalion were not detected. Results The procedure was completed successfullyin 417 cases(96.5% ) and converted to traditional surgical closure with CPB in the other15 cases(3.5% ). Concentric devices were used in 238 cases(57.1% )and eccentric deviceswere used in 179 patients(42.9% ). Successful procedures finished in less than 90 minutes,and the deployment and evaluation of the devices were completed in 5 to 60 (18. 2 ± 8.6)minutes. No residual shunt and detectable aortic or tricuspid insufficiency and arrhythmiawas observed. Patients were extubated within 2 hours and discharged 3 to 5 days after theoperation. During fellow-up period from 3 months to 2 years, no clinically significantcomplications occurred. Conclusion The minimally invasive device closure of VSD under TEEguidance without CPB is proved to be a simple, safe and effective treatment for aconsiderable number of children with VSD. Its use in the clinical practice should beencouraged.
Identification of Risk Factors for Arrhythmia Post Transcatheter Closure of Perimembranous Ventricular Septal Defect

Yifei Li,Yimin Hua,Jie Fang,Chaomin Wan,Chuan Wang,Kaiyu Zhou

Abstract:Objective: Arrhythmias are frequently observed after transcatheter closure of perimembranous ventricular septal defect (pmVSD), especially in the early postprocedure period. Independent risk factors associated with postclosure arrhythmias are still elusive. The current study aimed to identify such risk factors via regression analysis with a long-term follow-up. Methods: A group of 553 patients from June 2003 to December 2010 who received symmetric Amplatzer-type pmVSD occluders for pmVSD in our center were followed for 2-8 years. The complications during the follow-up period were classified as early (within 1 year), continuous (persisted >1 year), or late (recurrent or onset after 1 year). We first evaluated the potential risk factors (age, procedure time, size of the defect, size of the occluder, diameter of the defect, distance of lesion to aortic rim, distance of lesion to tricuspid rim, presence of aneurysm, orifice size on aneurysm, arrhythmia before procedure, procedure time) by comparing complicated and uncomplicated cases using univariate analysis, then logistic analysis for independent risk factors. Results: We identified 90 cases of early, 59 cases of continuous, and 13 cases of late complications. The size of the occluder was identified as an independent risk factor for early, continuous, and late arrhythmias. Preexisting arrhythmias were found to be risk factors for early and late arrhythmias, while the distance between the defect and the tricuspid rim was identified as a risk factor for continuous arrhythmias. Conclusion: The size of the occluder, preexisting arrhythmias, and the distance between the defect and the tricuspid rim were found to be risk factors for arrhythmias after transcatheter closure of pmVSD. Selection of properly sized occluders might be crucial to reduce postclosure complications.
Perimembranous Ventricular Septal Defect Closure Via Ultra-Minimal Trans Intercostal Incision in Children.

Zhan Gao,Jin Yu,Zewei Zhang,Jianhua Li,Jiangen Yu

DOI: https://doi.org/10.1111/jocs.15760

IF: 1.778

2021-01-01

Journal of Cardiac Surgery

Abstract:Aims：This study aimed to investigate the safety, feasibility and availability of perimembranous ventricular septal defect (PmVSD) closure via a left parasternal ultra-minimal trans intercostal incision in children. Methods and results：From January 2015 to January 2019, 131 children with restrictive PmVSDs were enrolled in this study and successfully done in 126 patients (96.18%). PmVSDs were occluded via an ultra-minimal trans intercostal incision (≤1 cm), and the entire occlusive process was guided and monitored by TEE. A pericardium hanging technique was employed without sternal incision. PmVSDs were closed through a short delivery sheath assembled using a concentric occluder device. All patients were followed up for a perid ranging from18 months to 24 months. Thirteen patients with PmVSD had aneurysm of membranous septum (AMS). Multistream (more than or equal to 2) PmVSDs with AMS were found in eleven cases. After the operation, mild residual shunt beside the amplatzer occluder in one patient was found and had self-healing result during the 5-month follow-up period. Five patients transferred to ventricular septal defect repair operation under direct visualization with a cardiopulmonary bypass. One reason was ventricular fibrillation when guide wire passed the PmVSD, another was device dislocation, and others were the guide wire cannot pass through the PmVSD. Conclusions：PmVSDs closure using a concentric occluder via a left parasternal ultra-minimal trans intercostal incision under TEE guidance is feasible, safe, and effective in children. This approach can be considered as an alternative treatment to open-heart surgery for restrictive PmVSDs.
Comparative analysis of perimembranous and high ventricular septal defects closure via an ultra-minimal trans-intercostal incision guided by transesophageal echocardiography in children

傅行鹏,叶菁菁,俞劲,张泽伟,尤海容,谈林华

DOI: https://doi.org/10.3760/cma.j.cn101785-202212030-003

2023-01-01

Abstract:Objective:To explore the characteristics and prognoses of perimembranous and high ventricular septal defects (VSD) closure via a ultra-minimal trans-intercostal incision (i.e.left parasternal intercostal ultra-minimal incision≤1 cm) in children guided by transesophageal echocardiography (TEE) and provide references for such mini-invasive surgery.Methods:From January 2015 to December 2021, 344 cases of VSD closure via a left parasternal ultra-minimal trans-intercostal incision in children guided by TEE.According to the location of VSD, they were divided into two groups of perimembranous VSD (239/344, 69.5%) and high VSD (outflow tract & high membrane)(105/344, 30.5%). Operative procedures, operative duration, postoperative complications, prognoses and other relevant data of two groups were compared.Results:Among them, 229 cases (229/239, 95.8%) of perimembranous VSD and 100 cases (100/105, 95.2%) of high VSD were successfully occluded.No significant difference existed in success rate ( P>0.05). However, operative duration of perimembranous VSD was longer than that of high VSD ( P<0.05). In both groups, diameter of VSD was correlated positively with diameter of occluder, but not with operative duration.Among 239 cases of perimembranous VSD and 105 cases of high VSD, 12 cases (12/239, 5.0%) and 5 cases (5/105, 4.8%) were successfully re-occluded after adjusting or replacing occluder.No significant inter-group difference existed in success rate of re-occlusion ( P>0.05). A total of 10 children in perimembranous VSD group failed to occlude, including 7 cases (7/239, 2.9%) in which guide wire could not pass through VSD, 2 cases (2/239, 0.8%) in which occluder slipped off and 1 case of ventricular fibrillation.There were 5 cases of occlusion failure in high VSD group, including 1 case in which guide wire could not pass through VSD during operation (1/105, 1.0%), 1 case with occluder displacement during operation and 1 case post-operation (2/105, 1.9%), 1 case with aggravation of aortic regurgitation and 1 case with marked decrease in blood pressure.There was no significant inter-group difference in failure rate when guide wire could not pass through VSD and occluder slipped off or shifted( P>0.05). During a follow-up period of (1-4) days in perimembranous VSD group, there were 1 case of mild mitral regurgitation and 4 cases of mild-to-moderate tricuspid regurgitation.No change occurred during 6-month follow-ups.During a follow-up period of (1-4) days in high VSD group, one case developed right ventricular outflow tract obstruction and flow velocity declined during 6-month follow-ups.There were residual slight shunt ( n=19), pericardial effusion ( n=19) and pleural effusion ( n=4) in two groups.They were self-cured during 6-month follow-ups. Conclusion:Through a ultra-minimal trans-intercostal incision guided by TEE, perimembranous and high VSD closure offers a high success rate and an excellent postoperative recovery in children.Although operative duration of high VSD is shorter, diameter of VSD is not a sole influencing factor of operative duration.
Doubly Committed Ventricular Septal Defect Closure Using Eccentric Occluder Via Ultraminimal Incision

Jin Yu,Lianglong Ma,Jingjing Ye,Zewei Zhang,Jianhua Li,Jiangen Yu,Guoping Jiang

DOI: https://doi.org/10.1093/ejcts/ezx269

IF: 4.534

2017-01-01

European Journal of Cardio-Thoracic Surgery

Abstract:This study aimed to investigate the safety, feasibility and availability of doubly committed ventricular septal defect (DCVSD) closure via an ultraminimal intercostal incision under the guidance of transoesophageal echocardiography in children. From August 2014 to August 2016, 35 children with DCVSDs (a parts per thousand5 mm in diameter) were enrolled in this study. A left parasternal ultraminimal intercostal incision (a parts per thousand1 cm) and a pericardium hanging technique were employed without sternal incision. DCVSDs were closed through a short delivery sheath assembled with an eccentric occluder device. Transoesophageal echocardiography was used to guide and monitor the entire procedure. All patients were followed up. All 35 children had complete closures with an operation success rate of 100%. The average size of DCVSDs was 3.50 +/- 0.79 (range 2.2-5.0) mm, and the average device size was 5 +/- 2 (range 4-9) mm. The average operation duration was 45.42 +/- 11.77 (range 25-70) min, and the average hospital stay was 8 +/- 2 (range 7-16) days. The median follow-up period was 17 months (range 6 months-2.5 years). Pre-existing aortic regurgitation disappeared after surgery in 1 patient and remained the same in 4 patients. No other complications were found during the operation or during follow-up. Under transoesophageal echocardiography guidance, DCVSD closure using an eccentric occluder via an ultraminimal intercostal incision is feasible, safe and effective in children. The use of this approach is recommended.
Risk Factors of Long-Term Sequelae After Transcatheter Closure of Perimembranous Ventricular Septal Defect in Young Children

Chia-Yi Chin,Chun-An Chen,Chun-Min Fu,Jui-Yu Hsu,Hsin-Chia Lin,Shuenn-Nan Chiu,Ya-Mei Chang,Chun-Wei Lu,Heng-Wen Chou,Shu-Chien Huang,Yih-Sharng Chen,Mei-Hwan Wu,Jou-Kou Wang,Ming-Tai Lin

DOI: https://doi.org/10.1253/circj.cj-23-0891

2024-02-08

Circulation Journal

Abstract:BACKGROUND: Complications arising from transcatheter closure of perimembranous ventricular septal defects (pmVSD) in children, such as residual shunts and aortic regurgitation (AR), have been observed. However, the associated risk factors remain unclear. This study identified risk factors linked with residual shunts and AR following transcatheter closure of pmVSD in children aged 2-12 years.Methods and Results: The medical records of 63 children with pmVSD and a pulmonary-to-systemic blood flow ratio <2.0 who underwent transcatheter closure between 2011 and 2018 were analyzed with a minimum 3-year follow-up. The success rate of transcatheter closure was 98.4%, with no emergency surgery, permanent high-degree atrioventricular block, or mortality. Defects ≥4.5 mm had significantly higher odds of persistent residual shunt (odds ratio [OR] 6.85; P=0.03). The use of an oversize device (≥1.5 mm) showed a trend towards reducing residual shunts (OR 0.23; P=0.06). Age <4 years (OR 27.38; 95% confidence interval [CI] 2.33-321.68) and perimembranous outlet-type VSD (OR 11.94, 95% CI 1.10-129.81) were independent risk factors for AR progression after closure.CONCLUSIONS: Careful attention is crucial for pmVSDs ≥4.5 mm to prevent persistent residual shunts in transcatheter closure. Assessing AR risk, particularly in children aged <4 years, is essential while considering the benefits of pmVSD closure.

cardiac & cardiovascular systems
Leishmania mexicana: serial cultivation of intracellular stages in a cell-free medium.

A. Pan

DOI: https://doi.org/10.1016/0014-4894(84)90022-5

IF: 2.132

1984-08-01

Experimental Parasitology

Abstract:
Transcatheter Closure of Congenital Perimembranous Ventricular Septal Defect in Children Using Symmetric Occluders: an 8-Year Multiinstitutional Experience.

Lei Wang,Sancheng Cao,Jun Li,Lifang Yang,Yin Liu,Jun Ren,Qiaomei Ma,Haijian Xing,Dan Li,Danqiu Tian,Yi Wan,Shiqiang Yu,Tao Chen,Xiuling Yang,Jian Yang

DOI: https://doi.org/10.1016/j.athoracsur.2012.03.067

IF: 5.113

2012-01-01

The Annals of Thoracic Surgery

Abstract:Background. Perimembranous ventricular septal defects (pmVSDs) are one of the most common forms of congenital cardiac malformation in children. Results of transcatheter pmVSD closure remain debatable, prompting the need for further evaluation with regard to the safety and efficacy of this procedure. The aim of the study was to analyze the safety, efficacy, and long-term follow-up data associated with transcatheter closure of pmVSDs in children using symmetric occluders.Methods. From December 2002 to October 2011, 525 children with pmVSDs between 2 and 12 years of age underwent transcatheter closure at three major heart centers in northwest China with symmetric pmVSD occluders. All patients were followed up until October 2011 with electrocardiogram and transthoracic echocardiography. Adverse events were recorded and evaluated.Results. There were 252 male and 273 female patients with an average weight of 21.5 kg. The mean age at the time of transcatheter closure was 5.6 years, and the average ratio of pulmonic to systemic blood flow was 2.5. Transcatheter intervention was successfully performed in 502 patients (95.6%). The median device size implanted was 6.5 mm (range, 4 to 18 mm). During a median 45-month follow-up period, no mortality occurred. A total of three major adverse events (0.6%) were reported; two were valve-related. Meanwhile, 104 minor adverse events were detected during the entire follow-up period. All individuals experiencing major adverse events were younger than 3 years of age. The incidence of major adverse events in patients younger than 3 years old was significantly higher than that of patients older than 3 years old (3.75% versus 0.00%; Fisher's exact test p = 0.004).Conclusions. Data from the current study suggest that transcatheter pmVSD closure using symmetric occluders displayed an excellent success rate and long-term follow-up results. The transcatheter approach provides a less-invasive alternative to open surgery and displays some promise in the treatment of pmVSDs in certain patient populations. (Ann Thorac Surg 2012;94:592-8) (c) 2012 by The Society of Thoracic Surgeons
Analysis and Comparison of Failure Causes of Minimally Invasive Surgical Closure of Ventricular Septal Defects in Children

Jin Yu,Zhuo Shi,Jingjing Qian,Lianglong Ma,Baofu Zhang,Liyang Ying,Qiang Shu

DOI: https://doi.org/10.1136/wjps-2022-000432

2023-01-01

World Journal of Pediatric Surgery

Abstract:Objectives The aims of the present study were to explore the causes of minimally invasive surgical ventricular septal defect (VSD) closure failure under transesophageal echocardiography guidance and thus to improve the success rate of surgical VSD closure.Methods From January 2015 to December 2019, 522 children with VSD underwent minimally invasive surgical closure. Nineteen procedures (3.64%) were unsuccessful. The failure causes, VSD locations and surgical incision approaches were retrospectively analyzed.Results Among the 19 patients (3.64%) with unsuccessful outcomes, 18 were switched to cardiopulmonary bypass (CPB) surgery, and 1 was closed successfully using an occlusion device a year later. The causes of failure included occlusion device shedding or shifting (n=6), failure of the guidewire (or the sheath) to pass through a small defect (n=5), device-related valve regurgitation (n=4), significant residual shunt (n=2), ventricular fibrillation (n=1), and continuous sharp blood pressure decreases (n=1). Patients with high VSD had a slightly higher failure rate than those with perimembranous VSD (p=0.049), and its key reason is the high proportion of occlusion device shedding or shifting (p=0.001). No significant difference in the failure rate was found between patients with different surgical incision approaches.Conclusions Minimally invasive surgery has a high success rate for perimembranous VSDs. Occlusion device shedding or shifting is the most common cause of failure. The shedding or shifting risk of eccentric occlusion devices being used only for high VSDs is much greater than that of concentric occlusion devices being used for perimembranous VSDs, which increases the risk of conversion to CPB surgery for high VSDs.
[Risk factors for accelerated junctional escape rhythm in children early after percutaneous ventricular septal defect closure]

Li Wei,Li-Na Qiao,Yong-Yi Lu,Yi-Min Hua,Yi-Bin Wang,Qiang-Hua Ye,Xiao Wang,Xin-Hui Li

Abstract:Objective: To identify the risk factors for accelerated junctional escape rhythm (AJER) in children early after percutaneous ventricular septal defect (VSD) closure. Methods: A retrospective controlled study was conducted on 42 children who had AJER within one week after percutaneous VSD closure between January 2008 and October 2012. These subjects were compared with controls without AJER after VSD closure in terms of age, sex, diameter of VSD, occluder size, difference between occluder size and diameter of VSD, and distance between VSD and aortic valve ring. Risk factors for AJER were identified by logistic regression analysis. Results: Compared with the control group, the AJER group had a longer distance betweenVSD and aortic valve ring, a larger diameter of VSD (basal diameter), a larger occluder size (waist diameter) , and a bigger difference between the waist diameter of occluder and diameter of VSD (P<0.05). Logistic regression analysis showed that distance between VSD and aortic valve ring (OR=1.813, P<0.05) and occluder size (OR=1.671, P<0.05) are primary risk factors for AJER. Conclusions: AJER early after percutaneous VSD closure is related to diameter of VSD, occluder size, difference between the waist diameter of occluder and diameter of VSD, and distance between VSD and aortic valve ring. The distance between VSD and aortic valve ring and occluder size are primary risk factors for AJER.
Influence of percutaneous catheter intervention for congenital perimembranous ventricular septal defects in children on the cardiac conduction system and associated risk factors: a meta-analysis

Yu-Qing Lei,Wen-Hao Lin,Shi-Hao Lin,Wen-Peng Xie,Jian-Feng Liu,Qiang Chen,Hua Cao

DOI: https://doi.org/10.1186/s13019-022-01751-8

2022-02-16

Journal of Cardiothoracic Surgery

Abstract:Abstract Background The aim of this study was to investigate adverse outcomes and risk factors for the cardiac conduction system in children with perimembranous ventricular septal defects (pmVSDs) who had been treated by catheter intervention. Method PubMed, EMBASE, Web of Science, and the Cochrane Library were searched for studies in English on interventional treatment of pmVSDs in pediatric patients published up to the end of October 15, 2020. We used random- or fixed-effect models to obtain pooled estimates of the success rate and postoperative complications. Results A total of 1650 pediatric patients from 8 publications were included, with a mean age ranging from 3.44 to 8.67 years old. The pooled estimate of successful implantation was 98.2% (95% CI 97.1–99.4%, I 2 = 69.4%; P < 0.001), and the incidence of cardiac conduction system complications was 17.4% (95% CI 8.4–26.4%, I 2 = 96.1%; P < 0.001), among which the incidence of heart block was 14.8% (95% CI 6.4–23.3%, I 2 = 96.9%; P = 0.001). The incidence of impulse formation disorders was 4.1% (95% CI 0.7–7.6%, I 2 = 91.7%; P = 0.019), and the incidence of complete atrioventricular block was 0.8% (95% CI 0.3–13%, I 2 = 0.0%; P = 0.001). Risk factors for newly emerging arrhythmias included the VSD size MD = 0.89 (95% CI 0.46–1.32, I 2 = 0%; P < 0.0001) and device size MD = 1.26 (95% CI 0.78–1.73, I 2 = 0%; P < 0.00001). Conclusions Percutaneous catheter intervention is safe and effective in treating pediatric patients with pmVSD, and the risk factors leading to arrhythmias include the sizes of the pmVSD and device.

surgery,cardiac & cardiovascular systems
Transcatheter closure of perimembranous ventricular septal defects in children following transthoracic echocardiography]

Chun-hong Xie,Cheng-sen Xia,Ying-bao Zhou

DOI: https://doi.org/10.3785/j.issn.1008-9292.2006.06.016

2006-01-01

Abstract:To evaluate the efficacy and safety of transcatheter closure of perimembranous ventricular septal defects (VSD) in children following transthoracic echocardiography (TTE).From September 2002 to December 2005, eighty-nine children (47 males and 42 females) with perimembranous (VSD) underwent an attempt of transcatheter interventional occlusion. Among the 89 children, one of them was diagnosed with patent ductus arterious (PDA) and six with VSD leakage after the surgical repair (three with leakage after the surgical repair of tetralogy of Fallot and three with leakage after the surgical repair of VSD). The mean age of patients was (6.4 +/- 3.9) years (ranged from 1 to 18 years). The mean body weight of patients was (22 +/- 11 )kg (ranged from 9 to 78 kg). The mean diameter of VSD measured by TTE was (4.3 +/- 1.5) mm(ranged from 2 to 8.5mm). The path of artery to vein was established following X-rays and TTE. Occluder was released through the right heart system. All patients were followed up in 1, 3, 6 and 12 months after procedure of TTE, X-ray and electrocardiography.The devices were deployed successfully in 85 patients, the rate of success was 95.5%. No death occurred during and after the procedure. There was trivial residual shunt in 12 patients immediately after the closure by TTE and angiography. Twenty-four hours later, only 3 patients had trivial residual and no shunt existed after 6 months follow-up. Convulsion occurred in 1 case due to serious cardiac arrhythmias. Hemolysis was found in 2 cases. Other complications included 2 cases of complete left bundle branch block, 1 cases of left anterior fascicular block and 3 cases of incomplete right bundle branch block. They recovered after 3 to 7 days of corticosteroid treatment. After 1 to 36 months (mean 9 months) follow-up, none of occluders displacement occurred and no valve was involved.Transcatheter closure of membranous VSD using occluder would be safe and effective for children, and the results of short-term was satisfied. Transcatheter closure of VSD following TTE is a feasible method. TTE has the potential benefit of avoiding general anesthesia and esophageal intubation in children.
The efficacy and its mid-to long-term follow-up of transcathter closure of post-surgery residual ventricular septal defect of congenital heart disease

Lu ZHAO,Fang LIU,Lin WU,Lan HE,Chun-hua QI,Jia HOU,Ying LU,Guo-ying HUANG

DOI: https://doi.org/10.3969/j.issn.1673-5501.2014.05.009

2014-01-01

Abstract:Objective To evaluate the safety and efficacy of transcatheter closure of post-surgery residual ventricular septal defect( VSD)and its mid-to long-term follow-up results. Methods The clinical data of patients with post-surgery residual VSD who underwent an attempt of percutaneous device closure from September 2002 to December 2013 in Childrenˊs Hospital of Fudan University were summarized. Results 21 patients( 11 males and 10 females ) with post-surgery residual VSD underwent an attempt of percutaneous device closure in our center. The mean age was 8. 8 years(2. 7-21 years)and the mean weight was 26. 3 kg(10. 5-53. 5 kg). Among these 21 patients,their previous surgery procedures were VSD repair in 13 cases,repair of tetralogy of Fallot( TOF)in 5 cases,repair of double outlet right ventricle( DORV)in 2 cases,and repair of complete transposition of great arteries( TGA)with VSD in 1 case. In addition,1 patient of post-TOF repair was associated with frequently premature ventricular contraction and ventricular tachycardia,2 patients of post VSD repair were associated with recoarctation of the aorta. The duration between previous surgery and transcathter device closure was 11-80 months. The mean diameter of VSDs in right ventricle( RV) side was 3. 73 mm(1. 6-6. 3 mm)by angiogram. There were multiple shunts in RV side in 4 patients,and one patient was left ventricle to right atrium shunt. The Qp/Qs ratio was 1. 53 ± 0. 23,and there was no pulmonary hypertension more than moderate. Amplatzer devices were successfully deployed in all cases except for 1 failure case due to a repeat complete block during the arterial-venous loop establishing,and 2 devices were used in 1 patient. The median device size was 6. 5 mm(4 -12 mm). A radio-frequency ablation and 2 balloon dilatations were successfully finished for the associated defects in the same procedure. There was no procedure-related adverse events. Mild residual shunt was showed by angiogram and transthoracic echocardiography( TTE ) immediate after closure in 3 patients. Three patients with moderate to severe tricuspid regurgitation before device closure improved significantly after closure. All patients were doing well clinically in a mean 22. 2 months(1 - 79 months)follow up. Minor arrhythmia was observed in 2 patients in the first year follow-up ECG including incomplete right bundle branch and first-degree atrioventricular block,and remained the same in another 6 months to 1 year follow-up. All 3 residual shunts disappeared in the follow-up echocardiography except for a 3. 4 mm residual shunt still existed in 1 patient with normal heart size and function. No new onset tricuspid or aortic regurgitation was showed. There was no device malposition or embolization,or thrombosis formation. Conclusion Transcatheter closure of post-surgery residual ventricular septal defect is safe,effective and less trauma. The mid-to long-term follow-up results of these cases are promising.
Application of real-time electrocardiogram monitor in occlusion of ventricular septal defect

LU Ying,SHENG Feng,WU Lin,LIU Fang,HUANG Guoying

DOI: https://doi.org/10.3969/j.issn.1008-0740.2010.02.011

2010-01-01

Abstract:Objective To evaluate the use of real-time electrocardiogram(ECG) monitor in transcatheter occlusion of ventricular septal defect(VSD).Methods 65 patients including 3 residual VSD after surgical repair and 62 membranous ventricular septal defect were performed transcatheter occlusion in Children's Hospital of Fudan University from 2002 to 2008.Real-time ECG(GE Prucka CardioLab 4000 workstation) monitor was routinely used during the procedure.Results All VSD cases were confirmed by left ventricle angiogram.Arrhythmia happened in 13 of 65 cases(20%) during or after the operation.The occlusion failed in 6 cases due to recurrent severe arrhythmia detected by real-time ECG monitor when established the femoral A-V wire-track:Ⅲ degree atrioventricular bundle block(Ⅲ° AVB),complete left bundle branch block(CLBBB),Ⅲ?AVB combined with CLBBB,and intraventricular block combined with ventricular tachycardia(VT)in 2,2,1 and 1 case,which may result in persistent arrhythmia after occlusion.Arrhythmia were detected in 7 of 59 cases(90.7%) with successful occlusion:4 cases had complete right bundle branch block(CRBBB)and recovered after releasing the occluder,3 cases had transient incomplete right bundle branch block(ICRBBB)when the A-V wire-track was established,then followed with Ⅲ° AVB with non-persistent ventricular tachycardia(VT)or CLBBB after the occlusion,in which the arrhythmia disappeared in 2~3 days with steroid therapy.Conclusion The prevalence of arrhythmia is much higher in transcatheter closure of VSD than that in other interventional procedures.Real-time ECG monitor is valuable in detecting arrhythmia during and after the occlusion.
Perventricular device closure of the ventricular septal defects in children-first experience in the United Arab Emirates

Aleksandr Omelchenko,Neerod Kumar Jha,Nishant Shah,Antoine AbdelMassih,Juan Pablo Montiel,Benedict Raj Rajkumar

DOI: https://doi.org/10.1186/s13019-024-02959-6

2024-07-10

Abstract:Background: Ventricular septal defect (VSD) is the most common congenital cardiac malformation, accounting for approximately 30% of congenital heart defects. Conventional surgical repair using cardiopulmonary bypass is invasive and associated with morbidities and prolonged hospital stay. With the advent of interventional approaches and availability of different occluding devices, the technique of perventricular device closure is evolving and being implemented successfully in larger groups of patients. We present herein, our initial experience of perventricular device closure for the ventricular septal defects in children to assess risks and benefits. Methods: From March, 2023 to February, 2024, we have performed perventricular closure of ventricular septal defects in 13 children, under guidance of transesophageal echocardiography without cardiopulmonary bypass support. The median age at operation was 2 year (range 1.3-10 years) with the median body weight 11 kg (range 8.7-16.6 kg). Sixty-nine percent were males. The ventricular septal defect sizes ranged from 2.7 to 6 mm (mean 4.7 mm). Seven defects were perimembranous, four sub-aortic and two were muscular. One patient also underwent pulmonary artery de-banding with pulmonary artery balloon angioplasty and other one patent ductus arteriosus ligation, concomitantly. For defect closure, we used ventricular septal defect occlusion device (MemoPart™, Lepu Medical Technology Company, China) through a 3-cm skin incision in the lower- third of the sternum. The device sizes ranged from 5 to 8 mm (mean 6.9+-1.8 mm) and all patients except for two required symmetrical devices. Results: All patients underwent device closure successfully. The procedural duration ranged between 32 and 52 min. None of the patients required cardiopulmonary bypass. The mean ventilation time and intensive care unit stay was 3 and 24 h, respectively. None of the patients required inotropic support or blood transfusions. Moreover, no patients developed any arrhythmias including heart block. The average length of hospital stay was 4.4 days. At the latest follow up, there were no residual shunts, conduction disturbances, device dislodgement or major aortic or tricuspid valve complications seen in any patients. There was no mortality. Conclusions: Perventricular device closure of ventricular septal defects is a less invasive, extremely safe and effective method in children. It is associated with very fast recovery, shorter hospitalization time and better cosmetic incision. Moreover, it avoids cardiopulmonary bypass. The modifications and refinements in the design, material and implantation techniques will help in expanding the indications and prevent complications in the long-term.

Effects of geldanamycin and thalidomide on the Th1/Th2 cytokine balance in mice subjected to operative trauma.

[Risk factors for arrhythmia early after transcatheter closure of perimembranous ventricular septal defects]

[Risk factors for early arrhythmias post transcatheter closure of perimembranous ventricular septal defects]

Non-fluoroscopic percutaneous transcatheter closure of atrial septal defects in children under transesophageal echocardiographic guidance

Minimally Invasive Experiences on Perventricular Device Closure of Ventricular Septal Defects in Children

Application of Transesophageal Echocardiography in High Ventricular Septal Defect Closure Via the Small Intercostal Incision with Eccentric Occluder in Children

Minimally Invasive Perventricular Device Closure of Perimembranous Ventricular Septal Defect Without Cardiopulmonary Bypass: Multicenter Experience and Mid-Term Follow-Up

Identification of Risk Factors for Arrhythmia Post Transcatheter Closure of Perimembranous Ventricular Septal Defect

Perimembranous Ventricular Septal Defect Closure Via Ultra-Minimal Trans Intercostal Incision in Children.

Comparative analysis of perimembranous and high ventricular septal defects closure via an ultra-minimal trans-intercostal incision guided by transesophageal echocardiography in children

Doubly Committed Ventricular Septal Defect Closure Using Eccentric Occluder Via Ultraminimal Incision

Risk Factors of Long-Term Sequelae After Transcatheter Closure of Perimembranous Ventricular Septal Defect in Young Children

Leishmania mexicana: serial cultivation of intracellular stages in a cell-free medium.

Transcatheter Closure of Congenital Perimembranous Ventricular Septal Defect in Children Using Symmetric Occluders: an 8-Year Multiinstitutional Experience.

Analysis and Comparison of Failure Causes of Minimally Invasive Surgical Closure of Ventricular Septal Defects in Children

[Risk factors for accelerated junctional escape rhythm in children early after percutaneous ventricular septal defect closure]

Influence of percutaneous catheter intervention for congenital perimembranous ventricular septal defects in children on the cardiac conduction system and associated risk factors: a meta-analysis

Transcatheter closure of perimembranous ventricular septal defects in children following transthoracic echocardiography]

The efficacy and its mid-to long-term follow-up of transcathter closure of post-surgery residual ventricular septal defect of congenital heart disease

Application of real-time electrocardiogram monitor in occlusion of ventricular septal defect

Perventricular device closure of the ventricular septal defects in children-first experience in the United Arab Emirates